Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CX516 Adjunctive Therapy in Schizophrenia
NCT00235352Phase 3Completed
- Sponsor
- North Suffolk Community Services
- Start
- Feb 2002
- Primary completion
- Apr 2005
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cx516 in schizophrenia, sponsored by North Suffolk Community Services. Started Feb 2002; status: completed.
02
Drugs
cx516
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00235352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00235352.